Montreal woman first in the world to receive promising new breast cancer treatment
Robin Berman got the diagnosis in October: triple-negative breast cancer (TNBC).
It's a rare and aggressive form of breast cancer that is notoriously difficult to treat, and the risk of recurrence is high.
The news was crushing. Freshly retired and with her kids all grown up, Robin had just begun a new chapter in her life.
That chapter became overrun with doctor's appointments, medical tests and strange new medications.
"When I think back to that time, it was very emotional. It was very difficult, just to kind of accept that that was happening," Robin, 53, told CTV News.
"I had to have some discussions with my husband that I wish I didn't have to have at this time in my life. But we just decided together, we're just going to do this. We're going to focus on the treatments."
And just a few months into those treatments, things are turning around: the lump in Robin's breast is gone.
It's promising news amid an ongoing clinical trial called TROPION-Breast04, which uses a novel combination of therapies to target TNBC.
Robin is the first person in the world to receive this experimental treatment.
"I'm glad to contribute to science, to maybe help other women feel very hopeful that if they do get a diagnosis of triple-negative breast cancer, that there is hope," she said.
Robin is being treated at the McGill University Health Centre (MUHC) Research Institute in Montreal. She's under the care of Dr. Jamil Asselah, a leading oncologist in Quebec and a member of the trial's steering committee.
Robin Berman undergoes her fourth round of treatment for triple-negative breast cancer. (Courtesy image)
"[Robin] was the first person to start in the whole world. We were the first country in the world to open the study, [and the] MUHC was the first site in the world," Asselah said in an interview.
The trial has since gone global, with 19 countries signed on to participate.
So far, the results are promising.
"It's randomized trials, meaning half of the patients go to the standard of care, which is classic chemotherapy, and the other half go to the experimental treatment," the doctor explained. "All the patients that are on experimental treatment are doing very well, at least in our sight here at the MUHC."
TNBC: Hard to treat
Between 10 and 15 per cent of breast cancer cases are triple-negative, according to the latest data.
TNBC doesn't have any of the receptors that are usually found in breast cancer: estrogen, progesterone, and a protein called human epidermal growth factor.
This means treatments targeted for these receptors, such as hormone therapy, aren't effective. And if the cancer progresses far enough, it has a higher chance of coming back.
"That's the challenge: so we give classic chemotherapy, which is killing bad cells and good cells, but it's not specific to the TNBC. And that's why we don't have very good success stories," said Asselah.
"If you don't treat it early, if you don't give the best systemic treatment early, the risk of recurrence is very high."
The new treatment uses what doctors call an antibody-drug conjugate, intended to target tumour cells without harming healthy cells. This experimental medication, called Dato-DXd, is combined with the immunotherapy drug Durvalumab, which is already on the market.
"When we do this combo, we are expecting to have less side effects and higher pathologic complete response," Asselah explained.
So far, Robin has undergone four of the eight rounds of treatment she'll receive before surgery, during which tissue will be removed for analysis.
"We remove the specimen, the bed of the cancer, and we give the specimen to our colleagues and they check under the microscope if they find invasive cells. If they don't find invasive cells, we are winners," Asselah summarized.
Post-surgery, Robin will undergo another eight rounds of treatment.
Planning for the future
While there's still a ways to go in her cancer journey, Robin is optimisitic. She said she experienced a near-instant change after starting the therapy.
"Feeling the medication attacking your tumour like that, it's like a heat-seeking missile. And the next month, I didn't feel the tumour anymore."
Since then, "I've had a mammogram and an ultrasound to prepare for my surgery. And the radiologist told me there is nothing left on my scan."
While she endures the remainder of her treatments, Robin is planning for what lies ahead.
Robin Berman pictured shortly after her cancer diagnosis in November 2023. (Courtesy image)
"I decided I have to do something for me for my future, because doing something for my future gives me a future," she said.
An avid hiker and bird watcher, she enrolled in a program at the end of 2023 to become a "forest bathing" guide. Forest bathing, also called shinrin-yoku, is a therapeutic practice developed in Japan that promotes a mindful connection with nature.
"[It's about] using nature, reconnecting with nature to help heal your body and prevent chronic disease," said Robin. "So when this is done, I can continue to do that and maybe help other women who are going through the same thing -- use nature to help heal their body."
In the meantime, she's encouraging any women in a similar situation to her own to inquire about all their options.
"I would say, ask your oncologist, are there any trials that you can participate in? Not only are you advancing science, but you may get access to newer medications."
Have a news tip? We'd like to hear your story. Please send an email to MontrealDigitalNews@BellMedia.ca
CTVNews.ca Top Stories
'A beautiful soul': Funeral held for baby boy killed in wrong-way crash on Highway 401
A funeral was held on Wednesday for a three-month-old boy who died after being involved in a wrong-way crash on Highway 401 in Whitby last week.
'Sophisticated' cyberattacks detected on B.C. government networks, premier says
There has been a "sophisticated" cybersecurity breach detected on B.C. government networks, Premier David Eby confirmed Wednesday evening.
Police handcuff man trying to enter Drake's Toronto mansion
Toronto police say a man was taken into custody outside Drake's Bridle Path mansion Wednesday afternoon after he tried to gain access to the residence.
Biden says he will stop sending bombs and artillery shells to Israel if they launch major invasion of Rafah
U.S. President Joe Biden said for the first time Wednesday he would halt shipments of American weapons to Israel, which he acknowledged have been used to kill civilians in Gaza, if Prime Minister Benjamin Netanyahu orders a major invasion of the city of Rafah.
Rookie goalie Arturs Silovs to start for Canucks in Game 1 vs. Oilers
Rookie goalie Arturs Silovs will start in net for the Canucks as Vancouver kicks off a second-round series against the Edmonton Oilers Wednesday night.
Nijjar murder suspect says he had Canadian study permit in immigration firm's video
One of the Indian nationals accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar says in a social media video that he received a Canadian study permit with the help of an Indian immigration consultancy.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Quebec premier defends new museum on Quebecois nation after Indigenous criticism
Quebec Premier Francois Legault is defending his comments about a new history museum after he was accused by a prominent First Nations group of trying to erase their history.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his brain more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.